Skip to search.
 FTSE 100 Down 0.11%

BIND Therapeutics, Inc. (BIND)

-NasdaqGS
6.84 0.00(0.00%) 24 Apr 21:00
Add to Portfolio
Prev Close:6.84
Open:N/A
Bid:6.51 x 100
Ask:8.00 x 1000
1y Target Est:15.50
Beta:N/A
Earnings Date:6 May - 11 May (Est.)
Day's Range:N/A - N/A
52wk Range:4.89 - 13.72
Volume:0
Avg Vol (3m):431,530
Market Cap:139.49m
P/E (ttm):N/A
EPS (ttm):-1.97
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIND 0.00%139.49m
BMYDown 0.30%109.67b
PGNX 0.00%419.93m

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.38
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-2.00
Quarterly EPS Est (Mar-15) :-0.51
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company, develops various targeted and programmable therapeutics. It is developing Accurins that are designed with specific pharmaceutical characteristics intended to target tumors at... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback